2024 KY AETC Conference: Caring for Vulnerable Populations

Taking HIV Care to The Streets: How Street Medicine Meets the Unsheltered Homeless Where They're At

Activity Details
  • Credit Amounts:
    • CME: 0.75
    • CPE: 0.75
    • CDE: 0.75
    • ASWB ACE: 0.75
    • CNE: 0.75
  • Cost: Free
  • Release: Jun 1, 2024
  • Expires: Jun 1, 2027
  • Estimated Time to Complete:
    45 Minutes
  • Average User Rating:
    ( Ratings)

This CE activity was recorded from the live event "KY AETC Annual Conference: Caring for Vulnerable Populations" dated April 26-27, 2024. If you claimed credit for the live event you should not claim credit for this module.


Tyler B.  Evans Tyler B. Evans, MD, MS, MPH, AAHIVS, DTM&H, FIDSA
Chief Executive Officer & Co-Founder
Wellness and Equity Alliance
Scotts Valley, California

James Withers James Withers, MD
Medical Director
Pittsburgh Mercy’s Operation Safety Net
Pittsburgh, Pennsylvania

Needs Statement

According to the CDC 36,136 people received an HIV diagnosis in the United States and dependent areas in 2021. The annual number of new diagnoses decreased 7% from 2017 to 2021. It is critical for professionals to have current knowledge to provide effective treatment and education for patients. The CDC also states that Kentucky is at high risk for an HIV outbreak if introduced into the drug using population. HIV therapy was previously limited due to lack of treatment options, but more therapy options increase choice for patient treatment and challenges for providers. Screening for drug misuse is critical to the prevention of or early intervention in addiction.

Street Medicine (SM) involves delivering healthcare to unsheltered homeless individuals in their environment, focusing on trust and rapport-building. The philosophy of SM emphasizes addressing social determinants of health to provide comprehensive care to this vulnerable population. SM values establishing long-term relationships with patients to achieve better health outcomes and support their well-being by breaking barriers to care by meeting homeless individuals where they are, providing medical assistance and holistic support and reducing health disparities through targeted outreach, preventive care, mental health services, and substance abuse treatment.

Target Audience

Physicians, physician assistants, advanced practice nurses, nurses, pharmacists, dentists, social workers, health educators and therapists who currently provide or could provide care services to persons living with HIV/AIDS or Hepatitis C.


Upon completion of this activity, participants will be able to:
1. Discuss the Philosophy and History of Street Medicine (SM): Review the origins, philosophy, and evolution of the street medicine movement as shared by Jim, recognizing how this approach specifically addresses the unique needs of unsheltered homeless populations.
2. Recognize the Impact of HIV Among Unhoused Populations: Attendees will gain insights into the significant burden of HIV among unhoused populations and understand why addressing this issue is critical for meeting national End the HIV Epidemic (EHE) goals.
3. Explore the Syndemic Approach to HIV Care: Attendees will be introduced to the concept of a syndemic approach, which considers the interaction of HIV with other social and health issues, and how this approach can be effectively applied using the street medicine toolkit to better serve homeless populations with HIV.
4. Describe Operational Models of HIV Street Medicine: The audience will explore various operational models of street medicine tailored to the HIV care of homeless individuals, particularly those models implemented in California, to identify actionable strategies and best practices.


In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This enduring material is designated for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

IPE Competencies

  • Values/Ethics for Interprofessional Practice
  • Roles/ Responsibilities
  • Interprofessional Communication

This knowledge-based activity will award 0.75 contact hours (0.075 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

This online course meets regulatory requirements for 0.75 hours credit as permitted by 201 KAR 8:532 for dentists and 201 KAR 8:562 for dental hygienists.

As a Jointly Accredited Organization, UK HealthCare CECentral is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. UK HealthCare CECentral maintains responsibility for this course. Social workers completing this course receive 0.75 clinical continuing education credits.

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 nursing contact hours.

Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

None of the planners, faculty, and others in control of educational content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.


This program is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U1OHA30535 as part of an award totaling $4.2m. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.

“Funding for this presentation was made possible by cooperative agreement U1OHA30535 from the Health Resources and Services Administration HIV/AIDS Bureau. The views expressed do not necessarily reflect the official policies of the Department of Health and Human Services nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Any trade/brand names for products mentioned during this presentation are for training and identification purposes only.”

This content is owned by the AETC, and is protected by copyright laws.  Reproduction or distribution of the content without written permission of the sponsor is prohibited, and may result in legal action.